Product Information
CFMTI is a novel allosteric modulator of metabotropic glutamate receptors (mGluRs). It is being developed for the treatment of female infertility. The drug has been shown to be orally bioavailable in rats and to increase the responsiveness of ovarian follicles to gonadotropins. CFMTI may also have therapeutic potential in the treatment of depression, anxiety disorders, Parkinson's disease, and schizophrenia.
Chemical properties
Technical inquiry about: 3D-PJB86417 CFMTI
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.